DrugsControl Media Services

News Detail

As Covid cases rise, Serum Institute restarts manufacture of Covishield (13-04-2023)

New Delhi, 12 April 2023: Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection.


He said the company already has six million ......
View Details

Source : PTI
Serum Institute SII Adar Poonawalla Covid-19 vaccine Covishield

Related News